and arabinoxylan further enhanced SCFA production and improved intestinal barrier function. These findings advance our understanding of arabinoxylan-microbiota interactions and may guide the development of functional foods with enhanced health benefits.
He et al. (Thu,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: